Search results
Showing 1966 to 1980 of 2170 results for guidelines
reporting indicate existing regulations, good practices, standards and guidelines to follow when using AI methods, where appropriate...
Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
The organisation is split into 9 directorates: Show Centre for Guidelines Develops guidance on: the promotion of good health the...
Learn from NICE International, part of the UK's National Institute for Health and Care Excellence, about how to improve your nation's health and wellbeing
Our modular updates framework ensures flexibility and consistency in updating our manuals and helps prioritise important updates.
First NICE-curated guideline announced ahead of World Duchenne Awareness Day
In the lead-up to World Duchenne Awareness Day on Sunday 7 September, we’re pleased to announce the completion of our first assessment of an externally developed clinical guideline.
NICE wants as many people as possible to be able to use our services, and we have designed it to be accessible.
We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.
Biggest shake-up in type 2 diabetes care in a decade announced
Millions of people are set to benefit from earlier access to newer type 2 diabetes treatments – the biggest shake-up in care for a decade – as part of NICE’s commitment to re-evaluate priority clinical pathways described in the 10-Year Health Plan for the NHS.
Recommendations in NICE’s type 2 diabetes guideline update, published today, will enhance the use of SGLT-2 inhibitors in primary care and address these health inequalities.
The guidance development timeline
Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.
The standing committees were responsible for the development of our public health guidance.
IMI and H2020 Grant funded projects with NICE